Related Experiment Video
Updated: May 13, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Protein C deficiency as the major cause of thrombophilias in childhood
Shouichi Ohga1, Akira Ishiguro, Yukihiro Takahashi
1Department of Perinatal and Pediatric Medicine, Kyushu University, Fukuoka, Japan. ohgas@pediatr.med.kyushu-u.ac.jp
Insights
Inherited thrombophilias in Japanese children differ from Caucasians, with protein C deficiency being most common. Early intervention for pediatric protein C deficiency is crucial for optimal treatment.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Thromboembolism predisposition varies by race.
- Factor V Leiden and factor II mutations are common in Caucasians but absent in Asians.
- Low protein S (PS), protein C (PC), and antithrombin (AT) activity are observed in Japanese adults with deep vein thrombosis.
Purpose of the Study:
- To outline inherited thrombophilias in Japanese children.
- To investigate the genetic basis of congenital thrombophilias in pediatric patients.
- To inform early intervention and treatment strategies for pediatric protein C deficiency.
Main Methods:
- Analysis of congenital thrombophilias in 48 Japanese patients under 20 years old.
- Identification of mutations in protein S (PROS1), protein C (PROC), and antithrombin (SERPINC1) genes.
- Comparison of genetic findings between pediatric and adult thrombophilia patients.
Main Results:
- Protein C deficiency was the most frequent congenital thrombophilia (45%) in Japanese children, followed by PS deficiency (15%) and AT deficiency (10%).
- Homozygous or compound heterozygous mutations in PROC were found in 50% of PC-deficient children, with PC-nagoya (1362delG) identified in half of these cases.
- Severe neonatal complications like intracranial lesions and purpura fulminans were common in PC-deficient infants, even with non-inherited deficiency.
Conclusions:
- Inherited thrombophilias in Japanese children have a distinct molecular epidemiology compared to Caucasians.
- Protein C deficiency, particularly with homozygous/compound heterozygous mutations, poses significant risks in early infancy.
- Understanding the molecular basis of pediatric thrombophilia is essential for developing targeted interventions and optimizing anticoagulant therapy.
Abstract:
Genetic predisposition of thromboembolism depends on the racial background. Factor V Leiden (G1691A) and factor II mutation (G20210A) are the leading causes of inherited thrombophilias in Caucasians, but are not found in Asian ancestries. Protein S (PS), protein C (PC) and antithrombin (AT) activity are reportedly low in 65% of adult Japanese patients with deep vein thrombosis. Approximately half of the patients with each deficiency carry the heterozygous mutation of PS (PROS1; 20%), PC (PROC; 10%), and AT genes (SERPINC1: 5%). Recently, several studies have revealed an outline of inherited thrombophilias in Japanese children. Congenital thrombophilias in 48 patients less than age 20 years consisted of 45% PC deficiency, 15% PS deficiency and 10% AT deficiency, along with other causes. All PS- and AT-deficient patients had a heterozygous mutation of the respective gene. On the other hand, PC-deficient patients were considered to carry the homozygous or compound heterozygous mutation in 50%, the heterozygous mutation in 25%, and unknown causes in the remaining 25% of patients. Half of unrelated patients with homozygous or compound heterozygous PROC mutations carried PC-nagoya (1362delG), while their parents with its heterozygous mutation were asymptomatic. Most of the PC-deficient patients developed intracranial lesion and/or purpura fulminans within 2 weeks after birth. Non-inherited PC deficiency also conveyed thromboembolic events in early infancy. The molecular epidemiology of thrombosis in Asian children would provide a clue to establish the early intervention and optimal anticoagulant therapy in pediatric PC deficiency.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Clot Retraction and Fibrinolysis